MedTrace Logo

Total Neoadjuvant Treatment Combined With Adaptive Radiotherapy for Rectal Cancer

NCT05883800 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2024-03-19

No results posted yet for this study

Summary

Diarrhea was the most frequently reported severe adverse event in the treatment regime of pre-operative sequential short-course radiotherapy followed by chemotherapy (so called total neo-adjuvant treatment).

This study therefore investigates the benefit of on-couch adaptation for locally advanced rectal cancer patients undergoing this treatment regime.

Conditions

Interventions

RADIATION

On-couch adaptive radiotherapy

A new treatment plan, guided by volumetric images, is created at each treatment session

Sponsors & Collaborators

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Unn Hege Lilleøren, MD · Dept. of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-22
Primary Completion
2026-12-31
Completion
2031-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05883800 on ClinicalTrials.gov